Софосбувир и Ледипасвир
HEPCVIR-L is indicated for the treatment of chronic hepatitis C virus genotype 1 infection in adults .
Buy Ledviklear Ledviclear is a combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C, a viral infection of the liver.
The drug Ledihep (Ledihep) is intended for the treatment of HCV of the first and fourth genotypes in patients with cirrhosis of the largest digestive gland and without it.
Ledikast & mdash; it is a drug from the pharmaceutical company Natco Pharma Limited, which is designed to treat 1, 4, 5, and 6 HCV genotypes.
Resof L tablet is a combination drug used to treat chronic hepatitis C infection.
MyHep LVIR Tablet - комбинированное лекарственное средство, используемое для лечения хронической инфекции гепатита С. Это лекарство следует использовать с особой осторожностью у пациентов с известной историей гепатита B из-за повышенного риска серьезных побочных реакций.
The drug Ledifos was created for the treatment of chronic HCV genotypes 1 and 4 in patients with and without cirrhosis.
Virpas is a combination of ledipasvir and sofosbuvir and is used to treat chronic (prolonged) hepatitis C, a viral infection of the liver.
